Abstract:Background Australia is known for its outdoor culture, with a large percentage of its population engaging in outdoor recreational activities, aquatic, non-aquatic and outdoor occupational activities. However, these outdoor enthusiasts face increased exposure to ultraviolet radiation (UVR), leading to a higher risk of skin cancer, including malignant melanoma (MM). Over the past 40 years, there has been a significant rise in skin cancer rates in Australia, with two out of three Australians expected to develop some form of skin cancer by age 70. Currently, skin cancer examinations are not endorsed in asymptomatic or low-risk individuals in Australia, with only high-risk individuals recommended to undergo regular skin examinations. Notably, the Melanoma Institute Australia suggests that one-half of patients identify MMs themselves, although this claim appears to be based on limited Australian data which may not reflect contemporary practice. Therefore this study sought to determine the percentage of patients who were able to self-identify MMs as lesions of concern when presenting for a skin cancer examination. Methods Multi-site, cross-sectional study design incorporating a descriptive survey and total body skin cancer screening, including artificial intelligence by a skin cancer doctor. Results A total of 260 participants with suspect MM lesions were biopsied, with 83 (31.9%) found to be melanomas. Of the true positive MMs only a small percentage of participants (21.7% specificity) correctly had concerns about the suspect lesion being a MM. These MMs were located primarily on the back (44.4%), shoulder (11.1%) and upper leg (11.1%). There was no significant difference in the size between those participants aware of a MM versus those who were not ( P = 0.824, 24.6 vs 23.4 mm 2 ). Significantly more males identified lesions of concern that were MMs as compared to females ( P = 0.008, 61.1% vs 38.9%, respectively). With regard to true negatives males and females were similar (52.1% vs 47.9%, respectively). With regard to false negatives ( n = 65), a greater percentage of males than females did not recognize the MM as a lesion of concern (66.2% vs 33.8%, respectively). Participants were more likely to correctly identify an invasive MM as opposed to an in situ MM (27.3% versus 21.3%). Conclusions Only a small percentage of participants in this study were able to self-identify either in situ or invasive MM as a lesion of concern with a tendency to identify the more advanced, thicker MMs. Given that MM is associated with a high mortality and cost of treatment, particularly when invasive, the inability of lay persons to identify these cancerous lesions will likely lead to delayed treatment and a possible adverse outcome. We believe the current melanoma screening practices in Australian general practice should be revisited to improve patient outcomes with regard to MM. Additionally, prevention campaigns should include images and primary risk factors for MM.

Predictors of malignancy in melanocytic lesions presenting as new lesions compared to baseline total body photography: A case–control study

Clinician’s Ability to Identify Non-Melanoma Skin Cancer on 3D-Total Body Photography Sectors that Were Initially Identified during In-Person Skin Examination with Dermoscopy

Performance of an automated total body mapping algorithm to detect melanocytic lesions of clinical relevance

Dermoscopic predictors of melanoma in small diameter melanocytic lesions (mini-melanoma): a retrospective multicentric study of 269 cases

Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines

A Clinicopathological Analysis of Melanocytic Nevi: A Retrospective Series

Invasive Scalp Melanoma: Role for Enhanced Detection Through Professional Training

DP23 Stage presentation of melanomas arising in the back: a 20-year retrospective study of site-specific distribution and review of the literature

Pathology of melanocytic lesions: New, controversial, and clinically important issues

Spectrum of malignant and premalignant skin lesions in 505 adult subjects at risk of skin cancers

Impact of Patient's Age and Physician's Professional Background on the Number Needed to Treat in Malignant Melanoma Detection

Dermoscopy and reflectance confocal microscopy of solitary flat pink lesions: A new combined score to diagnose amelanotic melanoma

Comparison of Extended Skin Cancer Screening Using a Three-Step Advanced Imaging Programme vs. Standard-of-Care Examination in a High-Risk Melanoma Patient Cohort

Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients

Melanoma in situ and low risk pT1a melanoma: Need for new diagnostic terminology

Cutaneous Malignant Melanoma:Clinicopathological Analysis of 70 Cases

Estimating malignancy risk of melanocytic choroidal tumours detected in the Australian National Eye Health Survey

Patients poorly recognize lesions of concern that are malignant melanomas: is self-screening the correct advice?

Evaluation of Multiple Tissue Levels Frequently Upstages Patients With Clinically Localized Thin Primary Cutaneous Melanoma

DP20 A case series identifying the clinical and histopathological characteristics of amelanotic melanoma

Tumor control and normal tissue complications in BNCT treatment of nodular melanoma: a search for predictive quantities